Channing Sebo | Associate Director Insights and Outcomes; Sequivity Technology
Merck Animal Health

Dr. Sebo graduated Iowa State University in 2015 with a Doctorate in Veterinary Medicine (DVM). In 2011 she received a double major in Biology and Animal Science from the University of Minnesota-Twin Cities. Dr. Sebo has worked with the Sequivity® Technology since 2013, leading the field expertise in vaccine design and implementation in swine in the United States and globally. Dr. Sebo also created and developed the Sequivity® Dashboard, a sequence analysis and data management tool, bringing disease tracking and vaccine design to veterinarians in the field. Dr. Sebo specializes in influenza, PCV3, rotavirus and any new and emerging pathogens.